What is ImmunityBio, Inc.'s income tax?

ImmunityBio, Inc. (IBRX) reported income tax of $9K in Q1 2026.

How has ImmunityBio, Inc.'s income tax changed year-over-year?

ImmunityBio, Inc.'s income tax increased by 103.8% year-over-year, from -$234K to $9K.

What is the long-term trend for ImmunityBio, Inc.'s income tax?

Over 4 years (2021 to 2025), ImmunityBio, Inc.'s income tax has grown at a 96.8% compound annual growth rate (CAGR), from $9K to -$135K.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

ImmunityBio, Inc. IBRX Income Tax

Income Tax at other companies

Bristol-Myers SquibbBMY

$561M+10.2%

Johnson & JohnsonJNJ

$755M-71.3%

Merck & Co.MRK

$709M-13.3%

Gilead SciencesGILD

$559M+67.4%

Immunovant, Inc.IMVT

$1.55M+921%

Protagonist TherapeuticsPTGX

-$1.5M—

Segments

By segment

See full

Reportable Segment$9K+104%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s income tax?: ImmunityBio, Inc. (IBRX) reported income tax of $9K in Q1 2026.
How has ImmunityBio, Inc.'s income tax changed year-over-year?: ImmunityBio, Inc.'s income tax increased by 103.8% year-over-year, from -$234K to $9K.
What is the long-term trend for ImmunityBio, Inc.'s income tax?: Over 4 years (2021 to 2025), ImmunityBio, Inc.'s income tax has grown at a 96.8% compound annual growth rate (CAGR), from $9K to -$135K.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.